XETRMAK
Market cap30mUSD
Dec 23, Last price
1.41EUR
1D
1.44%
1Q
-17.54%
Jan 2017
11.90%
Name
MATERNUS-Kliniken AG
Chart & Performance
Profile
Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company was founded in 1877 and is headquartered in Berlin, Germany.
Valuation
Title EUR in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 102,306 -4.12% | 106,697 -4.25% | 111,437 -2.50% | |||||||
Cost of revenue | 103,738 | 22,680 | 16,985 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | (1,432) | 84,017 | 94,452 | |||||||
NOPBT Margin | 78.74% | 84.76% | ||||||||
Operating Taxes | 1,674 | 1,251 | 521 | |||||||
Tax Rate | 1.49% | 0.55% | ||||||||
NOPAT | (3,106) | 82,766 | 93,931 | |||||||
Net income | (14,257) 1.28% | (14,077) 466.48% | (2,485) -74.17% | |||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
Debt | ||||||||||
Debt current | 6,468 | 36,791 | 30,533 | |||||||
Long-term debt | 163,919 | 196,751 | 207,302 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 22,805 | 2,512 | 7,535 | |||||||
Net debt | 161,172 | 231,098 | 224,958 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 2,524 | 4,329 | 17,244 | |||||||
CAPEX | (3,964) | (2,003) | (1,925) | |||||||
Cash from investing activities | (3,964) | (2,001) | (1,917) | |||||||
Cash from financing activities | 7,457 | (12,761) | (12,792) | |||||||
FCF | 46,216 | 92,595 | 109,051 | |||||||
Balance | ||||||||||
Cash | 8,051 | 5,196 | 13,578 | |||||||
Long term investments | 1,164 | (2,752) | (701) | |||||||
Excess cash | 4,100 | 7,305 | ||||||||
Stockholders' equity | (55,881) | (37,550) | (23,845) | |||||||
Invested Capital | 138,921 | 170,581 | 171,607 | |||||||
ROIC | 48.37% | 52.88% | ||||||||
ROCE | 63.00% | 63.92% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 20,970 | 20,970 | 20,970 | |||||||
Price | 2.82 | 4.70 14.63% | ||||||||
Market cap | 59,135 | 98,559 14.63% | ||||||||
EV | 221,949 | 327,519 | ||||||||
EBITDA | 8,313 | 95,032 | 105,569 | |||||||
EV/EBITDA | 26.70 | 3.10 | ||||||||
Interest | 7,553 | 5,776 | 6,010 | |||||||
Interest/NOPBT | 6.87% | 6.36% |